Middle East & Africa Sarcopenia Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Treatment Type (Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement, and Others) and Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others)

No. of Pages: 70    |    Report Code: BMIRE00030473    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Sarcopenia Treatment Market

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics

4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics

4.2 Market Drivers

4.2.1 Upsurge in Geriatric Population

4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults

4.3 Key Market Restraints:

4.3.1 Unavailability of Direct Interventions

4.4 Key Market Opportunities:

4.4.1 Products in Clinical Trial Phases

4.5 Future Trends:

4.5.1 Rising Awareness About Sarcopenia

4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis

6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type

6.1 Vitamin D and Calcium Supplement

6.1.1 Overview

6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.2 Protein Supplement

6.2.1 Overview

6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.3 Vitamin B12 Supplement

6.3.1 Overview

6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel

7.1 Pharmacies

7.1.1 Overview

7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

7.2 Retail Channels

7.2.1 Overview

7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.3 Online Channels

7.3.1 Overview

7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis

8.1 Middle East & Africa

8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

9.1 Overview

9.2 Growth Strategies in the Sarcopenia Treatment Market

9.3 Inorganic Growth Strategies

9.3.1 Overview

9.4 Organic Growth Strategies

9.4.1 Overview

10. Company Profiles

10.1 Abbott Laboratories

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Bayer AG

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Nestle Health Science SA

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Novartis AG

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Pfizer Inc

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Sanofi SA

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Amway Corp

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 GSK Plc

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Sarcopenia Treatment Market Segmentation

Table 2. Sarcopenia Drug Under Clinical Development

Table 3. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)

Table 4. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type

Table 5. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel

Table 6. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Country

Table 7. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type

Table 8. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel

Table 9. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type

Table 10. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel

Table 11. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type

Table 12. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel

Table 13. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type

Table 14. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel

Table 15. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market

Table 16. Recent Organic Growth Strategies in the Sarcopenia Treatment Market

Table 17. Glossary of Terms, Sarcopenia Treatment Market

List of Figures

Figure 1. Middle East & Africa Sarcopenia Treatment Market Segmentation, By Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

Figure 4. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030

Figure 5. Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 6. Protein Supplement : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 7. Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 8. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 9. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030

Figure 10. Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 11. Retail Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 12. Online Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 13. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 14. Middle East & Africa Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)

Figure 15. Middle East & Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 16. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)

Figure 17. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)

Figure 18. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 19. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 20. Growth Strategies in the Sarcopenia Treatment Market

The List of Companies - Middle East & Africa Sarcopenia Treatment Market

1. Abbott Laboratories 
2. Bayer AG 
3. Nestle Health Science SA 
4. Novartis AG 
5. Pfizer Inc 
6. Sanofi SA 
7. Amway Corp 
8. GSK Plc